4.7 Article

An HIV-Encoded Antisense Long noncoding RNA Epigenetically Regulates Viral Transcription

期刊

MOLECULAR THERAPY
卷 22, 期 6, 页码 1164-1175

出版社

NATURE PUBLISHING GROUP
DOI: 10.1038/mt.2014.29

关键词

-

资金

  1. NIHLB [R01AI084406]
  2. NIAID [R56 AI096861-01, PO1 AI099783-01]
  3. ARC Future Fellowship [FT130100572]
  4. Poliomyelitis Research Foundation James Gear International Fellowship
  5. National Research Foundation (South Africa) International Fellowship
  6. Australian Research Council [FT130100572] Funding Source: Australian Research Council

向作者/读者索取更多资源

The abundance of long noncoding RNAs (lncRNAs) and their wide range of functional roles in human cells are fast becoming realized. Importantly, lncRNAs have been identified as epigenetic modulators and consequently play a pivotal role in the regulation of gene expression. A human immunodeficiency virus-encoded antisense RNA transcript has recently been reported and we sought to characterize this RNA and determine its potential role in viral transcription regulation. The intrinsic properties of this human immunodeficiency virus-expressed lncRNA were characterized and the data presented here suggest that it functions as an epigenetic brake to modulate viral transcription. Suppression of this long antisense transcript with small single-stranded antisense RNAs resulted in the activation of viral gene expression. This lncRNA was found to localize to the 5 ' long-term repeats (LTR) and to usurp components of endogenous cellular pathways that are involved in lncRNA directed epigenetic gene silencing. Collectively, we find that this viral expressed antisense lncRNA is involved in modulating human immunodeficiency virus gene expression and that this regulatory effect is due to an alteration in the epigenetic landscape at the viral promoter.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Immunology

Micro RNA Targets in HIV Latency: Insights into Novel Layers of Latency Control

Ashley I. Heinson, Jeongmin Woo, Amey Mukim, Cory H. White, Bastiaan Moesker, Alberto Bosque, Celsa A. Spina, Christopher H. Woelk, Ben D. Macarthur, Nadejda Beliakova-Bethell

Summary: Despite significant progress in identifying cellular factors and pathways contributing to the latent HIV reservoir, the major obstacle to eradicating the virus remains. Noncoding genes, including microRNAs, have been implicated in regulating HIV expression during latency. This study revealed dysregulation of miRNAs in a primary CD4(+) T cell model of HIV latency, with a subset targeting pathways relevant to HIV expression and establishment of latency, such as the p53 signaling pathway.

AIDS RESEARCH AND HUMAN RETROVIRUSES (2021)

Article Virology

The Intact Noninducible Latent HIV-1 Reservoir Is Established in an In Vitro Primary TCM Cell Model of Latency

Indra Sarabia, Szu-Han Huang, Adam R. Ward, R. Brad Jones, Alberto Bosque

Summary: The establishment of HIV-1 latency has posed challenges for curing HIV-1. Current strategies to shock and kill the virus reservoir are not effective in inducing the majority of intact HIV-1 proviruses. The mechanisms behind the non-inducible HIV-1 reservoir still need further investigation.

JOURNAL OF VIROLOGY (2021)

Article Microbiology

Epigenomic characterization of latent HIV infection identifies latency regulating transcription factors

Stuart R. Jefferys, Samuel D. Burgos, Jackson J. Peterson, Sara R. Selitsky, Anne-Marie Turner, Lindsey I. James, Yi-Hsuan Tsai, Alisha R. Coffey, David M. Margolis, Joel Parker, Edward P. Browne

Summary: HIV latency in CD4 T cells is a major barrier to curing HIV infection, characterized by elevated activity of specific transcription factors like Forkhead TFs and Kruppel-like factors, as well as the involvement of the protein CTCF in establishing latency. Targeting these factors may lead to new strategies to eliminate the HIV reservoir.

PLOS PATHOGENS (2021)

Article Pharmacology & Pharmacy

Pharmacologic control of homeostatic and antigen-driven proliferation to target HIV-1 persistence

E. A. Innis, C. Levinger, M. A. Szaniawski, E. S. C. P. Williams, J. Alcami, A. Bosque, J. T. Schiffer, M. Coiras, A. M. Spivak, V Planelles

Summary: This study investigated FDA-approved oncology drugs and found that dasatinib, ponatinib, and trametinib can significantly reduce proliferation of memory CD4 T cells in HIV-infected individuals. Dasatinib, in particular, blocks both homeostatic and antigen-driven proliferation and aids in reducing the reservoir size. By inhibiting STAT5 phosphorylation, dasatinib hinders IL-7 induced proliferation and prevents spontaneous rebound in cells from people living with HIV-1.

BIOCHEMICAL PHARMACOLOGY (2021)

Article Multidisciplinary Sciences

An ultrasensitive planar array p24 Gag ELISA to detect HIV-1 in diverse biological matrixes

Callie Levinger, J. Natalie Howard, Jie Cheng, Pingtao Tang, Amit Joshi, Marta Catalfamo, Alberto Bosque

Summary: The assessment of HIV-1 persistence is challenging, with most commercially available tests focusing on the measurement of nucleic acid. Despite their high sensitivity, these assays have limitations in evaluating translational competent viral reservoirs.

SCIENTIFIC REPORTS (2021)

Correction Multidisciplinary Sciences

An ultrasensitive planar array p24 Gag ELISA to detect HIV-1 in diverse biological matrixes (vol 11, 23647, 2021)

Callie Levinger, J. Natalie Howard, Jie Cheng, Pingtao Tang, Amit Joshi, Marta Catalfamo, Alberto Bosque

SCIENTIFIC REPORTS (2021)

Article Education, Scientific Disciplines

Scalable Science Education via Online Cooperative Questioning

Courtney B. Hilton, Micah B. Goldwater, Dale Hancock, Matthew Clemson, Alice Huang, Gareth Denyer

Summary: A critical goal of science education is to design and implement scalable learning activities that foster deep conceptual understanding in students. This study presents a novel design that combines online question authoring with supporting activities to enhance cognitive engagement.

CBE-LIFE SCIENCES EDUCATION (2022)

Article Virology

Pharmacological Targeting of Sphingosine Kinases Impedes HIV-1 Infection of CD4 T Cells through SAMHD1 Modulation

Rachel S. Resop, Alberto Bosque

Summary: Inhibition of SPHK can reduce HIV-1 transmission between CD4 T cells and decrease susceptibility to infection, which may serve as a basis for developing strategies to prevent HIV-1 infection.

JOURNAL OF VIROLOGY (2022)

Article Biochemistry & Molecular Biology

Discovery of a large-scale, cell-state-responsive allosteric switch in the 7SK RNA using DANCE-MaP

Samuel W. Olson, Anne-Marie W. Turner, J. Winston Arney, Irfana Saleem, Chase A. Weidmann, David M. Margolis, Kevin M. Weeks, Anthony M. Mustoe

Summary: This study used a single-molecule chemical probing strategy, DANCE-MaP, to define the structural dynamics of 7SK RNA and revealed its role in regulating transcription and responding to cellular signals.

MOLECULAR CELL (2022)

Article Virology

The HIV Latency Reversal Agent HODHBt Enhances NK Cell Effector and Memory-Like Functions by Increasing Interleukin-15-Mediated STAT Activation

Amanda B. Macedo, Callie Levinger, Bryan N. Nguyen, Jonathan Richard, Mamta Gupta, Conrad Russell Y. Cruz, Andres Finzi, Katherine B. Chiappinelli, Keith A. Crandall, Alberto Bosque

Summary: In this study, we found that HODHBt enhances IL-15 signaling in natural killer cells, leading to increased cytotoxicity and memory-like functions. This suggests that pharmacological enhancement of IL-15-mediated STAT activation could be a new approach for HIV treatment.

JOURNAL OF VIROLOGY (2022)

Article Multidisciplinary Sciences

SARS CoV-2 mRNA vaccination exposes latent HIV to Nef-specific CD8+ T-cells

Eva M. Stevenson, Sandra Terry, Dennis Copertino, Louise Leyre, Ali Danesh, Jared Weiler, Adam R. Ward, Pragya Khadka, Evan McNeil, Kevin Bernard, Itzayana G. Miller, Grant B. Ellsworth, Carrie D. Johnston, Eli J. Finkelsztein, Paul Zumbo, Doron Betel, Friederike Dundar, Maggie C. Duncan, Hope R. Lapointe, Sarah Speckmaier, Nadia Moran-Garcia, Michelle Premazzi Papa, Samuel Nicholes, Carissa J. Stover, Rebecca M. Lynch, Marina Caskey, Christian Gaebler, Tae-Wook Chun, Alberto Bosque, Timothy J. Wilkin, Guinevere Q. Lee, Zabrina L. Brumme, R. Brad Jones

Summary: In a cohort of people with HIV, COVID mRNA vaccination leads to a temporary increase in a specific profile of HIV-specific T-cell responses and a corresponding decrease in residual HIV RNA, indicating productive immune engagement with infected cells.

NATURE COMMUNICATIONS (2022)

Article Biotechnology & Applied Microbiology

PolyIC-coated Prussian blue nanoparticles as a dual-mode HIV latency reversing agent

Preethi B. Balakrishnan, Carissa S. Holmberg, Debbie K. Ledezma, Alberto Bosque, Rohan Fernandes

Summary: This study investigates the use of nanoparticles as carriers to deliver drugs for the reactivation of latent HIV infection. The results show that polymeric-coated nanoparticles are more effective than free polymers in activating latent HIV and enhancing immune activation.

NANOMEDICINE (2022)

Article Oncology

Evaluation of the Elements of Short Hairpin RNAs in Developing shRNA-Containing CAR T Cells

Ryan Urak, Brenna Gittins, Citradewi Soemardy, Nicole Grepo, Lior Goldberg, Madeleine Maker, Galina Shevchenko, Alicia Davis, Shirley Li, Tristan Scott, Kevin V. Morris, Stephen J. Forman, Xiuli Wang

Summary: In this study, the impact of different shRNA elements on the knockdown efficiency of target genes in CAR T cells was evaluated. The results emphasize the importance of considering multiple shRNAs and their orientation for effective knockdown. It was also shown that using a strong promoter and avoiding self-targeting can enhance CAR T cell functionality. These findings provide a framework for the rational design of CAR T cells with shRNA-mediated knockdown capabilities, which can improve the therapeutic efficacy of CAR T cell-based immunotherapy.

CANCERS (2023)

Review Virology

IL-15 and N-803 for HIV Cure Approaches

J. Natalie Howard, Alberto Bosque

Summary: Despite advances in antiretroviral therapy, the latent reservoir of HIV-infected cells remains a major hurdle in finding a cure. IL-15 and N-803 have shown potential in reactivating latent HIV and enhancing immune effector function, which are crucial for reducing latent reservoirs.

VIRUSES-BASEL (2023)

Article Medicine, Research & Experimental

Combined noncanonical NF-κB agonism and targeted BET bromodomain inhibition reverse HIV latency ex vivo

Shane D. Falcinelli, Jackson J. Peterson, Anne-Marie W. Turner, David Irlbeck, Jenna Read, Samuel L. M. Raines, Katherine S. James, Cameron Sutton, Anthony Sanchez, Ann Emery, Gavin Sampey, Robert Ferris, Brigitte Allard, Simon Ghofrani, Jennifer L. Kirchherr, Caroline Baker, JoAnn D. Kuruc, Cynthia L. Gay, Lindsey I. James, Guoxin Wu, Paul Zuck, Inmaculada Rioja, Rebecca C. Furze, Rab K. Prinjha, Bonnie J. Howell, Ronald Swanstrom, Edward P. Browne, Brian D. Strahl, Richard M. Dunham, Nancie M. Archin, David M. Margolis

Summary: This study demonstrates the synergy in latent reservoir activation when using inhibitor of apoptosis protein (IAP) antagonists in combination with bromodomain and extraterminal domain protein inhibitors (BETi). It also highlights the importance of HIV transcriptional elongation and splicing as barriers to latent HIV protein expression, providing a rationale for further exploration of IAPi+BETi in animal models of HIV latency.

JOURNAL OF CLINICAL INVESTIGATION (2022)

暂无数据